HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Eckerd sale

This article was originally published in The Rose Sheet

Executive Summary

J.C. Penney will sell its Eckerd drugstore chain to Brooks Pharmacy owner Jean Coutu and drugstore retailer CVS for $4.53 bil., company announces April 5. Jean Coutu will acquire 1,539 Eckerd stores and support facilities located in thirteen Northeast and mid-Atlantic states, as well as the Eckerd home office for $2.38 bil. Stores under Jean Coutu will retain the Eckerd name. CVS will acquire 1,260 Eckerd stores and support facilities located in southern states including Florida, Texas and Arizona, in addition to Eckerd's pharmacy benefits management and mail order business, for $2.15 bil. The firm plans to reopen the Eckerd stores under the CVS name. Transactions are expected to close by the end of the second quarter, subject to regulatory approvals...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012031

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel